title: Cancer Stem Cells: A Moving Target.
abstract: Even though the number of anti-cancer drugs entering clinical trials and approved by the FDA has increased in recent years, many cancer patients still experience poor survival outcome. The main explanation for such a dismal prognosis is that current therapies might leave behind a population of cancer cells with the capacity for long-term self-renewal, so-called cancer stem cells (CSCs), from which most tumors are believed to be derived and fueled. CSCs might favor local and distant recurrence even many years after initial treatment, thus representing a potential target for therapies aimed at improving clinical outcome. In this review, we will address the CSC hypothesis with a particular emphasis on its current paradigms and debates, and discuss several mechanisms of CSC resistance to conventional therapies.
authors.affiliation: McGowan Institute for Regenerative Medicine, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA ; RiMed Foundation, 90133 Palermo, Italy.
authors.forename: Maria Giovanna
authors.initials: MG
authors.lastname: Francipane
authors.forename: Julie
authors.initials: J
authors.lastname: Chandler
authors.forename: Eric
authors.initials: E
authors.lastname: Lagasse
keywords: ABC transporters; CSCs; Cancer; Cancer stem cells; DNA repair; Drug resistance; Genomic instability; Pathobiology
references.citation: Nat Med. 2001 Sep;7(9):1028-34
references.pmid: 11533706
references.citation: Cell. 2009 Apr 17;137(2):216-33
references.pmid: 19379690
references.citation: Biochemistry. 2011 Mar 22;50(11):1901-9
references.pmid: 21261287
references.citation: Neoplasma. 2009;56(5):371-8
references.pmid: 19580337
references.citation: Nature. 2007 Oct 25;449(7165):1003-7
references.pmid: 17934449
references.citation: Hepatol Res. 2008;38(11):1112-21
references.pmid: 18624716
references.citation: Stem Cell Rev. 2008 Summer;4(2):67-79
references.pmid: 18401767
references.citation: Cancer Res. 1997 Mar 1;57(5):846-9
references.pmid: 9041184
references.citation: Nature. 2006 Dec 7;444(7120):756-60
references.pmid: 17051156
references.citation: Clin Cancer Res. 2010 Jun 15;16(12):3141-52
references.pmid: 20530696
references.citation: Science. 2012 Nov 23;338(6110):1080-4
references.pmid: 23087000
references.citation: Exp Mol Pathol. 2009 Apr;86(2):95-100
references.pmid: 19167378
references.citation: Stem Cells. 2011 Nov;29(11):1661-71
references.pmid: 21948564
references.citation: Cell. 2008 May 16;133(4):704-15
references.pmid: 18485877
references.citation: Nature. 2008 Dec 4;456(7222):593-8
references.pmid: 19052619
references.citation: Curr Mol Pharmacol. 2008 Jun;1(2):93-105
references.pmid: 19079736
references.citation: Br J Cancer. 2010 Apr 13;102(8):1265-75
references.pmid: 20332776
references.citation: Blood. 2012 Jun 28;119(26):6187-97
references.pmid: 22493298
references.citation: Cancer Lett. 2013 Sep 10;338(1):120-6
references.pmid: 22546285
references.citation: Int J Cancer. 1999 Oct 22;84(5):478-83
references.pmid: 10502724
references.citation: Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10158-63
references.pmid: 17548814
references.citation: Nature. 2012 Feb 15;482(7386):529-33
references.pmid: 22343890
references.citation: Cell. 1994 May 20;77(4):491-502
references.pmid: 7910522
references.citation: Nature. 2009 May 14;459(7244):262-5
references.pmid: 19329995
references.citation: World J Surg Oncol. 2012 Nov 15;10:244
references.pmid: 23153436
references.citation: Exp Cell Res. 2010 Aug 1;316(13):2099-112
references.pmid: 20457152
references.citation: FASEB J. 2012 Jun;26(6):2648-56
references.pmid: 22415308
references.citation: Mol Cancer Ther. 2010 Sep;9(9):2450-7
references.pmid: 20716638
references.citation: Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16281-6
references.pmid: 19805294
references.citation: Oncogene. 2012 Jan 5;31(1):93-103
references.pmid: 21666715
references.citation: Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):10002-7
references.pmid: 12890867
references.citation: Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8
references.pmid: 12629218
references.citation: Biomed Environ Sci. 2008 Aug;21(4):290-5
references.pmid: 18837291
references.citation: Cancer Cell. 2002 Dec;2(6):437-45
references.pmid: 12498712
references.citation: Nature. 2009 Jan 29;457(7229):608-11
references.pmid: 19092804
references.citation: Anticancer Res. 2010 Feb;30(2):319-25
references.pmid: 20332435
references.citation: Cell Cycle. 2012 Nov 1;11(21):4079-92
references.pmid: 23095522
references.citation: Blood. 2009 Dec 24;114(27):5415-25
references.pmid: 19797526
references.citation: Cell Stem Cell. 2012 Sep 7;11(3):415-28
references.pmid: 22958933
references.citation: Nature. 2007 Jan 4;445(7123):111-5
references.pmid: 17122771
references.citation: Oncogene. 2013 Oct 31;32(44):5191-8
references.pmid: 23334333
references.citation: Mol Cancer Res. 2008 Dec;6(12):1920-7
references.pmid: 19074836
references.citation: Eur J Cancer. 1998 Sep;34(10):1607-11
references.pmid: 9893637
references.citation: Nat Med. 2011 Aug 28;17(9):1086-93
references.pmid: 21873988
references.citation: Nat Med. 1997 Jul;3(7):730-7
references.pmid: 9212098
references.citation: Cell Cycle. 2009 Sep 15;8(18):2936-44
references.pmid: 19713741
references.citation: Environ Health Perspect. 1993 Dec;101 Suppl 5:15-26
references.pmid: 7516873
references.citation: Breast Cancer Res. 2010;12(3):R31
references.pmid: 20525204
references.citation: Nature. 2004 Nov 18;432(7015):396-401
references.pmid: 15549107
references.citation: Cancer Res. 2010 Jan 15;70(2):719-29
references.pmid: 20068153
references.citation: Nature. 2010 Jul 29;466(7306):632-6
references.pmid: 20639864
references.citation: Nat Cell Biol. 2010 May;12(5):468-76
references.pmid: 20418870
references.citation: Clin Cancer Res. 2010 Jun 15;16(12):3130-40
references.pmid: 20530699
references.citation: Clin Pharmacol Ther. 2011 Apr;89(4):491-502
references.pmid: 21368752
references.citation: Int J Cancer. 2001 Jan 1;91(1):67-75
references.pmid: 11149422
references.citation: Med Hypotheses. 2009 Oct;73(4):542-7
references.pmid: 19564079
references.citation: Cell Stem Cell. 2011 Jan 7;8(1):16-29
references.pmid: 21211780
references.citation: Science. 2012 Aug 10;337(6095):730-5
references.pmid: 22855427
references.citation: Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14228-33
references.pmid: 15381773
references.citation: Biomaterials. 2012 Jul;33(20):5107-14
references.pmid: 22494888
references.citation: Cell. 2009 May 29;137(5):811-9
references.pmid: 19490891
references.citation: Mol Pathol. 1997 Apr;50(2):57-71
references.pmid: 9231152
references.citation: Nucleic Acids Res. 2007;35(22):7557-65
references.pmid: 18160407
references.citation: Toxicol Sci. 2004 Nov;82(1):341-58
references.pmid: 15319485
references.citation: Cancer Cell. 2012 Mar 20;21(3):283-96
references.pmid: 22439924
references.citation: Am J Physiol Gastrointest Liver Physiol. 2011 Aug;301(2):G347-55
references.pmid: 21596996
references.citation: Nature. 1994 Feb 17;367(6464):645-8
references.pmid: 7509044
references.citation: Adv Exp Med Biol. 2012;727:272-88
references.pmid: 22399355
references.citation: Nature. 2007 Jan 4;445(7123):106-10
references.pmid: 17122772
references.citation: Mol Cancer. 2006 Dec 02;5:67
references.pmid: 17140455
references.citation: FEBS J. 2012 Jun;279(11):2047-59
references.pmid: 22498306
references.citation: Nat Genet. 2000 Jan;24(1):36-44
references.pmid: 10615124
references.citation: J Clin Invest. 2008 Jun;118(6):2111-20
references.pmid: 18497886
references.citation: J Cancer Res Clin Oncol. 2009 Oct;135(10):1369-76
references.pmid: 19340456
references.citation: Mutat Res. 2013 Jan-Mar;752(1):25-35
references.pmid: 23010441
references.citation: Proc Natl Acad Sci U S A. 2007 Jan 9;104(2):618-23
references.pmid: 17202265
references.citation: Cancer Res. 2008 Sep 1;68(17):6932-41
references.pmid: 18757407
references.citation: PLoS One. 2012;7(7):e41035
references.pmid: 22844424
references.citation: Stem Cells. 2011 Mar;29(3):418-29
references.pmid: 21308861
references.citation: Nature. 2010 Dec 23;468(7327):1095-9
references.pmid: 21150899
references.citation: Nature. 2005 Jun 16;435(7044):959-63
references.pmid: 15959515
references.citation: Science. 2001 Dec 7;294(5549):2155-8
references.pmid: 11739954
references.citation: J Cancer Res Clin Oncol. 2008 Nov;134(11):1155-63
references.pmid: 18470535
references.citation: PLoS One. 2011;6(7):e22733
references.pmid: 21829496
references.citation: Mutat Res. 2012 Aug 1;736(1-2):82-92
references.pmid: 22561673
references.citation: Cancer Res. 1993 Oct 15;53(20):4754-6
references.pmid: 7691404
references.citation: Cancer Res. 2010 Feb 15;70(4):1469-78
references.pmid: 20145124
references.citation: Lancet. 1995 Mar 11;345(8950):615-9
references.pmid: 7534855